Monthly Miracles 12-14

by , | Dec 1, 2014

Monthly

Miracles

by Michael Gerber, MD, HMD

Reversing Ischemic Heart Damage with Multiple Chelations and EECP

It is rare that a patient is so dedicated to health that he or she can employ multiple modalities to improve heart disease. Even more unusual is serial monitoring of one’s cardiac status by a world-class medical facility.

Our 85 year-old attorney with a history of chronic hypertension had been evaluated for many years at the Mayo Clinic in Scottsdale, Arizona. In 2010, a myocardial perfusion tomogram revealed inferior/inferolateral ischemia from near the apex to the base and extending into the inferoseptum from mid to base, approximately 12% of the left ventricular myocardium. There was no myocardial infarction. Left ventricular size was normal and left ventricular ejection fraction (poststress) was 56% to 60%. There was a new, mild hypokinesia involving the inferior wall of the left ventricle from mid to base on the posters images. Calcification score in the coronary arteries was over 4000. Summary interpretation: There was a moderate-sized area of moderately dense myocardial ischemia in the distribution of the right coronary artery. There was also a new poststress regional wall motion abnormality, due to postischemic stunning.

In 2011 an ECHO at Mayo noted a moderately severe increased concentric left ventricular wall thickness. Regional wall motion abnormalities were present with a grade 1a/4 left ventricular diastolic dysfunction with increased right ventricular wall thickness. Findings were also consistent with moderate pulmonary hypertension. Severe left atrial enlargement was noted.

Integrative Therapies

This 85 year-old patient has completed over 100 EDTA chelation infusions and over 300 EECP (enhanced extracorporeal counterpulsation) sessions. Additionally, he eats an organic, Paleo diet, exercises daily on a treadmill, and takes many supplements, including lumbrokinase. He is asymptomatic, his hypertension is well controlled, and he maintains an active law practice and even has a new girlfriend.

Reevaluation

At a May 2014 visit to Mayo, a repeat ECHO cardiogram revealed a lack of ischemia in the right coronary artery distribution and improved ventricular wall motion. The ejection fraction had also improved. According to the patient, the cardiologist at first thought that the interpretation may have been in error, but on review concurred that the improvement was substantial.

Advertisement

Although the patient’s heart architecture is still far from normal, it is encouraging to find this anecdotal case of reversing ischemia in a portion of the heart that had probably suffered a myocardial infarction in the distant past. Softening the heart with chelation therapy and fibrinolysis with lumbrokinase have thus been found to be marvelous strategies for improving heart health. EECP has a strong track record with much supporting data for its use in reversing and treating heart disease.1-2

Notes

  1. Whitaker J. Reversing Hypertension: A Vital New Program to Prevent, Treat, and Reduce High Blood Pressure. Grand Central Publishing; 2001.

  2. Braverman D. Heal Your Heart with EECP: The Only Non-Invasive Way to Overcome Heart Disease. Random House; 2005.

Authors

  • Michael Gerber, MD, HMD, MD(H), graduated from the Kansas University School of Medicine in 1972. He completed his internal medicine internship at Oakland County Hospital with additional training in Zaire, Africa. He also trained in a psychiatric externship at the crisis intervention ward at the University of California, San Francisco Medical School, and performed psycho-pharmacology research at the Stanford Research Ward of the Palo Alto, California, Veterans Administration Hospital and Menlo Park Veterans Administration Hospital.

    Dr. Michael Gerber has always been drawn to natural approaches to medicine, and early in his practice he studied with many well-known medical pioneers such as Dr. John Christopher, Dr. Paavo Airola, and two-time Nobel Prize Laureate Dr. Linus Pauling. He has been a chelating physician since 1976 and has been a diplomate of the American Board of Chelation Therapy since 1984. He is also a diplomate of the International College of Anti-Aging Medicine and is a graduate of the UCLA Medical Acupuncture Training Program. He is the president of the Nevada Homeopathic and Integrative Medical Association, a past president of the Orthomolecular Medical Association, and was a medical advisor and featured columnist for Alternative Medicine Magazine and the Townsend Letter.

    His Gerber Medical Clinic, Inc. is in Reno, Nevada.

    View all posts

Already Subscribed?

Search

Formatting updates are ongoing for older articles.

Author

Featured Articles

Where are your Clinical Trials?

It has proven to be difficult, if not impossible, to proceed to full-scale randomized controlled trials (RCTs) for most of the natural methods that cannot be patented or otherwise monopolized. 

A Renewed Focus on Self-Help for Healing

As the producer of The Moss Report, the year leading up to the Covid-19 pandemic was filled with anticipation and excitement. We had invested years of hard work and significant resources into two major projects: our feature film, Immunotherapy: The Battle Within, and...

Issue Archives

Event Calendar

  • Integrative Cancer Symposium 2026 – Believe BIG

    Sheraton, Towson MD Towson, MD, United States

    Optimize Your Health. Transform Your Future. Join us for this dynamic one-day experience designed for anyone seeking to take a proactive, whole-body approach to health. Integrative oncology is a dynamic and rapidly evolving field, unveiling groundbreaking discoveries and new possibilities every day. This year’s one-day conference will take place at the Sheraton in Towson, Maryland from 9am – 5pm and offers both in-person and virtual attendance options. This event brings together leading experts in integrative oncology, functional medicine, and wellness. Discover cutting-edge approaches to prevention, treatment, recovery, and whole-person wellness at the Integrative Cancer Symposium Believe Big 2026. Learn from leading clinicians, researchers, and innovators in integrative oncology as they explore emerging therapies, metabolic and lifestyle approaches, mistletoe therapy, nutrition, environmental health, mindset, and more. Whether you are navigating cancer personally, supporting a loved one, or simply looking to optimize your health and reduce future risk, this powerful one-day experience offers practical tools, fresh insights, and meaningful connection.

  • PLMI 14th Annual Thought Leaders Consortium

    Loews Coronado Bay Resort 4000 Coronado Bay Rd, Coronado, CA, United States

    The 14th Annual Thought Leaders Consortium marks the culminating chapter of PLMI’s three-year exploration into the biology of immuno-metabolism, epigenetic regulation, and human longevity. Building on the 2024 and 2025 Consortia—which reframed chronic disease through immune-metabolic dysfunction and diet- and environment-driven epigenetic remodeling—this year’s gathering places mitochondria at the center of health, disease, and aging. Once viewed simply as the cell’s energy producers, mitochondria are now recognized as dynamic, epigenetically responsive organelles that integrate nutrition, environmental exposures, immune activation, stress signaling, physical activity, and circadian inputs into a unified metabolic-immune system. Disruption of mitochondrial function is increasingly implicated in fatigue syndromes, chronic pain, immune dysregulation, neurodegeneration, infertility, metabolic disease, accelerated aging, and diminished stress resilience. This advanced, science-driven Consortium convenes world-leading experts to explore mitochondrial biology as the cornerstone of immuno-metabolic resilience. Attendees will gain cutting-edge insights into mitochondrial signaling, mito-nuclear communication, and metabolic flexibility—alongside clinically actionable frameworks for restoring cellular vitality, reversing biological aging trajectories, and extending healthspan. Through deep scientific exploration and translational clinical strategy, the 2026 Thought Leaders Consortium will equip practitioners and researchers with the knowledge needed to redefine assessment, intervention, and long-term outcomes in personalized and lifestyle medicine.

    $650
  • Practical Clinical Skills in Neurotransmitter Optimization: Clinical Herbalism for Mood, Cognition & Aging

    Virtual Event

    Join us for the second part of this two-part virtual symposium! Mental health and neurocognitive disorders remain among the most prevalent and inadequately addressed challenges in modern clinical practice.  This intensive, expert-led symposium provides a comprehensive, clinically grounded framework for integrating herbal and nutraceutical strategies into mental health care. Attendees gain a working understanding of how targeted herbal interventions modulate key neurotransmitter systems, including serotonin, dopamine, GABA, and cortisol, and how to apply these therapies strategically, whether as adjuncts to pharmaceuticals or as standalone options. Clinical applications span a wide spectrum, from anxiety and depression to Parkinson’s-related motor symptoms and age-associated cognitive decline, with a strong emphasis on practical implementation and patient-specific protocol design.

Related Posts

When Screens Replace Connection: Impact on Children’s Brains

By Erik Peper, PhD, BCB, Stoyan Vezenkov, PhD, Violeta Manolovab, Lauren Mason, PhD and Richard Harvey, PhD – The empirical record on educational technology in early and primary education has not delivered on its promises—math and reading scores have declined while screen use in classrooms has risen, as the US NAEP data and Sweden’s recent reversal of its “digital-first” education policy make plain.

Read More

0 Comments

Submit a Comment

Pin It on Pinterest

Share This